Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases

    May 26, 2023

    India as a Quad-led biomanufacturing hub

    May 25, 2023

    Manappuram Finance, Rossari Biotech shares trade ex-dividend today

    May 24, 2023
    Facebook Twitter Instagram
    Your Biotech
    • Bio Technology

      Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases

      May 26, 2023

      India as a Quad-led biomanufacturing hub

      May 25, 2023

      Manappuram Finance, Rossari Biotech shares trade ex-dividend today

      May 24, 2023

      Scottish Biotech ILC Therapeutics Signs R&D Partnership With Dechra Pharmaceuticals PLC

      May 23, 2023

      Israeli biotech phenom puts death knell on cancer

      May 22, 2023
    • Pharmaceutical

      Pharma company owner duped of ₹1.1 crore

      November 11, 2022

      Novavax cuts full-year revenue forecast again amid weak demand

      November 10, 2022

      Aurobindo units recall products in US market for manufacturing issues

      November 9, 2022

      AASLD 2022 | Ascentage Pharma Releases Phase I Results of IAP Antagonist APG-1387 in an Oral Report Showing Potential for Functionally Curing CHB

      November 8, 2022

      Trade Spotlight | What should you do with Amara Raja, Sun Pharma Advanced Research, Poly Medicure on Monday?

      November 7, 2022
    Your Biotech
    Home»Bio Technology»Study shows the de novo origination of functional microproteins
    Bio Technology

    Study shows the de novo origination of functional microproteins

    yourbiotechBy yourbiotechDecember 29, 2022Updated:December 29, 2022No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp VKontakte Email
    Share
    Facebook Twitter LinkedIn Pinterest Email

    In a recent study published in Cell Reports, researchers performed a genomic analysis to investigate the origination of human microproteins of biological importance.

    Studies have reported that sORFs (small open reading frames) encode functional microproteins essential for several biological processes. However, the origination and conservation of such microproteins have not been well-characterized. Genomic analysis of microproteins could deepen understanding of human genomic characteristics critical for functionality.

    About the study
    In the present study, researchers investigated the origin of functional human microproteins. They investigated cases wherein the proteins evolved from non-coding sequences and acquired biological importance.

    The study comprised open reading frames translated in a previous study (Chen et al) and were reported in the human FANTCOM-CAT transcriptome dataset by Hon et al. The analysis was restricted to ORFs situated on noncoding transcripts (‘new’), located upstream of coding ORF genes (‘upstream‘), located downstream of coding ORFs (‘downstream’), or situated on transcripts devoid of coding ORF genes but belonging to transcript families with one coding member (‘new_iso’). The team matched ORF genes from the aforementioned two previous studies on the basis of their chromosomal coordinate similarity, 100.0% sequence identities, and comparable lengths.

    In total, 715 ORFs, situated on 527 transcripts, were analyzed. Data on fitness effects, phenotypic scores, and classification based on their significance using induced pluripotent stem cells and obtained from previous studies. CPAT (coding potential assessment tool) was applied to ORF sequences to determine coding probability scores. Ribonucleic acid sequencing (RNA-seq) analysis data were mapped to their relevant genomic assemblies. Inference of orthologous transcription based on reference transcriptomes and expression data analysis was performed.

    Further, orthologous genomic regions were identified, and the presence of ancestral ORFs was inferred, following which functional signatures were assessed. To estimate the origination timing for every ORF (i.e. the most ancient ancestor with intact ORFs), the team searched for orthologous chromosomal regions of the human ORFs in genomic data of 99 species of vertebrates. The team aligned the orthologous sequences of all ORFs subjected to PhyloCSF (phylogenetic codon substitution frequencies) analysis. ASR (ancestral sequence reconstruction) analysis was performed to infer the absence or presence of ORFs at human ancestor nodes based on ORF lengths.

    The origination timing of microproteins was considered based on the first node at which ORFs and transcripts were detectable (putative origin) and was independent of the origination mode. In the case wherein ancestors lacking intact ORFs preceded ancestors possessing intact ones, the origination mode was termed de novo. Data on the origination timings of ORFs and transcripts were combined to infer the origination timing of microproteins with de novo origin. To evaluate the effect of ORF lengths, strict (50%) and relaxed (80%) de novo attribution values were assessed. The team investigated the biological importance/functionality of the de novo-emerged microproteins. All known single-nucleotide polymorphisms (SNPs) annotated as pathogenic or likely pathogenic were surveyed.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Previous ArticleBiological E and Bharat Biotech have a combined stockpile of 250 million COVID vaccination doses.
    Next Article Optical ‘tweezer’ enables fast, low-cost screening of bacteria and cancer cells
    yourbiotech
    • Website

    Related Posts

    Ironwood Enters into Definitive Agreement to Acquire VectivBio, a Clinical-Stage Biotech Company Pioneering Novel Treatments for Severe Rare Gastrointestinal Diseases

    May 26, 2023

    India as a Quad-led biomanufacturing hub

    May 25, 2023

    Manappuram Finance, Rossari Biotech shares trade ex-dividend today

    May 24, 2023

    Scottish Biotech ILC Therapeutics Signs R&D Partnership With Dechra Pharmaceuticals PLC

    May 23, 2023

    Leave A Reply Cancel Reply

    Our Picks

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us
    About Us

    We provide a wide range of customized, integrated B2B and B2C digital marketing services solutions that are ideal for your business.

    We're accepting new partnerships right now.

    Email Us: info@yourmartech.com
    Contact: +1-530-518-1420

    Our Brands
    • Your Martech
    • Your HR Tech
    • Your Fin Tech
    • Your Revenue
    • Your Info Tech
    • Your POS Tech
    • Your Health Tech
    SUBSCRIBE NOW
    Loading
    LinkedIn
    • Privacy Policy
    © 2022 Vigarbiz Inc. Designed by Vigarbiz Media

    Type above and press Enter to search. Press Esc to cancel.